Sun Pharma Advanced Research Co. Ltd.(IN:SPARC)
₹212.75+1.65 (+0.78%)
IN:SPARC
Sun Pharma Advanced Research Co. Ltd. financials statements
₹212.75
At close:+1.65 (+0.78%)
Want to see IN:SPARC full AI Analyst Report?
Sun Pharma Advanced Research Co. Ltd. (SPARC) Income Statement
8 Followers
Sun Pharma Advanced Research Co. Ltd. Income Statement
Last quarter (Q1 2027), Sun Pharma Advanced Research Co. Ltd.'s total revenue was ₹399.20M, an increase of 314.11% from the same quarter last year. In Q1, Sun Pharma Advanced Research Co. Ltd.'s net income was ₹-207.80M. See Sun Pharma Advanced Research Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 18.79B | ₹ 717.70M | ₹ 755.45M | ₹ 2.39B | ₹ 1.37B | |
| ₹ 17.27B | ₹ 486.50M | ₹ -1.24B | ₹ 821.21M | ₹ 105.52M | |
| ₹ 1.39B | ₹ 3.27B | ₹ 7.74B | ₹ 3.06B | ₹ 4.90B | |
| Depreciation and Amortization | ₹ 102.10M | ₹ 123.90M | ₹ 125.11M | ₹ 117.71M | ₹ 101.62M |
| ₹ 15.99B | ₹ -3.23B | ₹ -3.73B | ₹ -2.03B | ₹ -1.80B | |
| ₹ 15.89B | ₹ -2.78B | ₹ -4.12B | ₹ -2.24B | ₹ -1.97B | |
| ₹ -355.40M | ₹ -648.00M | ₹ 246.72M | ₹ 10.61M | ₹ -73.23M | |
| ₹ 15.53B | ₹ -3.43B | ₹ -3.87B | ₹ -2.23B | ₹ -2.03B | |
| ₹ 15.53B | ₹ -3.43B | ₹ -3.87B | ₹ -2.23B | ₹ -2.03B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 47.86 | ₹ -10.55 | ₹ -11.93 | ₹ -7.82 | ₹ -7.73 |
| Diluted EPS | ₹ 47.86 | ₹ -10.55 | ₹ -11.93 | ₹ -7.82 | ₹ -7.73 |
| Weighted Average Shares Outstanding | 324.53M | 324.65M | 324.52M | 284.70M | 263.14M |
| Weighted Average Shares Outstanding (Diluted) | 324.53M | 324.65M | 324.52M | 284.70M | 263.14M |
Currency in INR
